Delta-6-desaturase Links Polyunsaturated Fatty Acid Metabolism With Phospholipid Remodeling and Disease Progression in Heart Failure

Background— Remodeling of myocardial phospholipids has been reported in various forms of heart failure for decades, but the mechanism and pathophysiological relevance of this phenomenon have remained unclear. We examined the hypothesis that &dgr;-6 desaturase (D6D), the rate-limiting enzyme in long-chain polyunsaturated fatty acid biosynthesis, mediates the signature pattern of fatty acid redistribution observed in myocardial phospholipids after chronic pressure overload and explored plausible links between this process and disease pathogenesis. Methods and Results— Compositional analysis of phospholipids from hearts explanted from patients with dilated cardiomyopathy revealed elevated polyunsaturated fatty acid product/precursor ratios reflective of D6D hyperactivity, manifesting primarily as lower levels of linoleic acid with reciprocally higher levels of arachidonic and docosahexaenoic acids. This pattern of remodeling was attenuated in failing hearts chronically unloaded with a left ventricular assist device. Chronic inhibition of D6D in vivo reversed similar patterns of myocardial polyunsaturated fatty acid redistribution in rat models of pressure overload and hypertensive heart disease and significantly attenuated cardiac hypertrophy, fibrosis, and contractile dysfunction in both models. D6D inhibition also attenuated myocardial elevations in pathogenic eicosanoid species, lipid peroxidation, and extracellular receptor kinase 1/2 activation; normalized cardiolipin composition in mitochondria; reduced circulating levels of inflammatory cytokines; and elicited model-specific effects on cardiac mitochondrial respiratory efficiency, nuclear factor &kgr; B activation, and caspase activities. Conclusions— These studies demonstrate a pivotal role of essential fatty acid metabolism in myocardial phospholipid remodeling induced by hemodynamic stress and reveal novel links between this phenomenon and the propagation of multiple pathogenic systems involved in maladaptive cardiac remodeling and contractile dysfunction.

[1]  G. Hatch,et al.  Dietary linoleate preserves cardiolipin and attenuates mitochondrial dysfunction in the failing rat heart. , 2012, Cardiovascular research.

[2]  C. Koehler,et al.  The complexity of cardiolipin in health and disease. , 2012, Trends in biochemical sciences.

[3]  L. Kirshenbaum,et al.  Multiple facets of NF-κB in the heart: to be or not to NF-κB. , 2011, Circulation Research.

[4]  S. Prabhu,et al.  Cardiomyocyte NF-κB p65 promotes adverse remodelling, apoptosis, and endoplasmic reticulum stress in heart failure. , 2011, Cardiovascular research.

[5]  D. Graham,et al.  Cyclooxygenase and thromboxane/prostaglandin receptor contribute to aortic endothelium-dependent dysfunction in aging female spontaneously hypertensive rats. , 2009, Journal of applied physiology.

[6]  G. Hatch,et al.  Cardiolipin biosynthesis and remodeling enzymes are altered during development of heart failure , 2009, Journal of Lipid Research.

[7]  H. Aburatani,et al.  Cardiac 12/15 lipoxygenase–induced inflammation is involved in heart failure , 2009, The Journal of experimental medicine.

[8]  R. Murphy,et al.  Transcellular biosynthesis of cysteinyl leukotrienes in vivo during mouse peritoneal inflammation , 2009, Proceedings of the National Academy of Sciences.

[9]  M. Schlame,et al.  Formation of molecular species of mitochondrial cardiolipin. 1. A novel transacylation mechanism to shuttle fatty acids between sn-1 and sn-2 positions of multiple phospholipid species. , 2009, Biochimica et biophysica acta.

[10]  Takao Shimizu,et al.  Acyl-CoA:Lysophospholipid Acyltransferases* , 2009, Journal of Biological Chemistry.

[11]  R. Gross,et al.  Eicosanoid signalling pathways in the heart. , 2008, Cardiovascular research.

[12]  Thomas Illig,et al.  FADS genotypes and desaturase activity estimated by the ratio of arachidonic acid to linoleic acid are associated with inflammation and coronary artery disease. , 2008, The American journal of clinical nutrition.

[13]  J. Sundström,et al.  Markers of dietary fat quality and fatty acid desaturation as predictors of total and cardiovascular mortality: a population-based prospective study. , 2008, The American journal of clinical nutrition.

[14]  Thomas D. Schmittgen,et al.  Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.

[15]  S. Neubauer,et al.  Increased mitochondrial uncoupling proteins, respiratory uncoupling and decreased efficiency in the chronically infarcted rat heart. , 2008, Journal of molecular and cellular cardiology.

[16]  R. Murphy,et al.  Loss of cardiac tetralinoleoyl cardiolipin in human and experimental heart failure Published, JLR Papers in Press, April 10, 2007. , 2007, Journal of Lipid Research.

[17]  Xianlin Han,et al.  Alterations in myocardial cardiolipin content and composition occur at the very earliest stages of diabetes: a shotgun lipidomics study. , 2007, Biochemistry.

[18]  T. Ueland,et al.  Role of inflammation in the progression of heart failure , 2007, Current cardiology reports.

[19]  Stefan Neubauer,et al.  The failing heart--an engine out of fuel. , 2007, The New England journal of medicine.

[20]  K. Duffin,et al.  Novel, selective Δ6 or Δ5 fatty acid desaturase inhibitors as antiinflammatory agents in mice , 2007, Lipids.

[21]  G. Sparagna,et al.  Role of cardiolipin alterations in mitochondrial dysfunction and disease. , 2007, American journal of physiology. Cell physiology.

[22]  S. Rapoport,et al.  Lipids in Health and Disease , 2006 .

[23]  W. Paulus,et al.  Myocardial cytokine gene expression is higher in aortic stenosis than in idiopathic dilated cardiomyopathy , 2005, Heart.

[24]  R. Murphy,et al.  Quantitation of cardiolipin molecular species in spontaneously hypertensive heart failure rats using electrospray ionization mass spectrometry Published, JLR Papers in Press, March 16, 2005. DOI 10.1194/jlr.M500031-JLR200 , 2005, Journal of Lipid Research.

[25]  Manabu T. Nakamura,et al.  STRUCTURE, FUNCTION, AND DIETARY REGULATION OF Δ6, Δ5, AND Δ9 DESATURASES , 2004 .

[26]  C. Leslie Regulation of arachidonic acid availability for eicosanoid production. , 2004, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[27]  Manabu T. Nakamura,et al.  Structure, function, and dietary regulation of delta6, delta5, and delta9 desaturases. , 2004, Annual review of nutrition.

[28]  A. Sanbe,et al.  Changes in fatty acid compositions of myocardial lipids in rats with heart failure following myocardial infarction , 2004, Molecular and Cellular Biochemistry.

[29]  M. Sutton,et al.  COX-2–Dependent Cardiac Failure in Gh/tTG Transgenic Mice , 2003, Circulation research.

[30]  J. Nadler,et al.  Overexpression of 12-lipoxygenase and cardiac fibroblast hypertrophy. , 2003, Trends in cardiovascular medicine.

[31]  E. Blasi,et al.  Structural, functional, and molecular characterization of the SHHF model of heart failure. , 2002, American journal of physiology. Heart and circulatory physiology.

[32]  D. Burkhoff,et al.  Disease-specific remodeling of cardiac mitochondria after a left ventricular assist device. , 2002, The Annals of thoracic surgery.

[33]  J. Masferrer,et al.  Selective inhibition of Delta-6 desaturase impedes intestinal tumorigenesis. , 2002, Cancer letters.

[34]  K. Duffin,et al.  Lipid remodeling in mouse liver and plasma resulting from Δ6 fatty acid desaturase inhibition , 2001, Lipids.

[35]  J. McHowat,et al.  Redistribution and abnormal activity of phospholipase A(2) isoenzymes in postinfarct congestive heart failure. , 2001, American journal of physiology. Cell physiology.

[36]  G. Poli,et al.  4‐Hydroxynonenal in the Pathomechanisms of Oxidative Stress , 2000, IUBMB life.

[37]  P. Kang,et al.  Apoptosis and heart failure: A critical review of the literature. , 2000, Circulation research.

[38]  M. Portero-Otín,et al.  Double bond content of phospholipids and lipid peroxidation negatively correlate with maximum longevity in the heart of mammals , 2000, Mechanisms of Ageing and Development.

[39]  A. Folsom,et al.  Plasma fatty acid composition and 6-year incidence of hypertension in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. , 1999, American journal of epidemiology.

[40]  K. Duffin,et al.  Novel, selective delta6 or delta5 fatty acid desaturase inhibitors as antiinflammatory agents in mice. , 1999, Lipids.

[41]  G. FitzGerald,et al.  Prostaglandin F2α (PGF2α) and the Isoprostane, 8,12-iso-Isoprostane F2α-III, Induce Cardiomyocyte Hypertrophy , 1998, The Journal of Biological Chemistry.

[42]  I. Rodger,et al.  Induction of cyclooxygenase-2 and activation of nuclear factor-kappaB in myocardium of patients with congestive heart failure. , 1998, Circulation.

[43]  A. Omran,et al.  Increased oxidative stress in patients with congestive heart failure. , 1998, Journal of the American College of Cardiology.

[44]  G. FitzGerald,et al.  Prostaglandin F2alpha (PGF2alpha) and the isoprostane, 8, 12-iso-isoprostane F2alpha-III, induce cardiomyocyte hypertrophy. Differential activation of downstream signaling pathways. , 1998, The Journal of biological chemistry.

[45]  M. Karin,et al.  Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. , 1997, The New England journal of medicine.

[46]  D. Girelli,et al.  Increased membrane ratios of metabolite to precursor fatty acid in essential hypertension. , 1997, Hypertension.

[47]  P. Singal,et al.  Role of oxidative stress in transition of hypertrophy to heart failure. , 1996, Journal of the American College of Cardiology.

[48]  R. Vasan,et al.  The progression from hypertension to congestive heart failure. , 1996, JAMA.

[49]  H. Esterbauer,et al.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.

[50]  B. O’Rourke,et al.  Altered phospholipid metabolism in pressure-overload hypertrophied hearts. , 1986, The American journal of physiology.

[51]  G. Summer,et al.  Improved method for hydroxyproline analysis in tissue hydrolyzates. , 1971, Analytical biochemistry.